Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear decrease » linear increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
linear decrease » linear increase (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
4841
MXene-Coated Liquid Metal Nanodroplet Aggregates
Published 2025“…In contrast to silicone-based composites containing LM droplets or MXene nanosheets alone, these MXene-LM-silicone-based composites exhibit an exponential increase in thermal and electrical conductivity with decreasing interfacial thickness with significantly lower LM volume fractions (25 vol %) while avoiding LM rupture and bleed-out. …”
-
4842
Baseline characteristics of the participants.
Published 2024“…<div><p>Locomotive Syndrome (LS) is defined by decreased walking and standing abilities due to musculoskeletal issues. …”
-
4843
Internal validation by cross-validation.
Published 2024“…<div><p>Locomotive Syndrome (LS) is defined by decreased walking and standing abilities due to musculoskeletal issues. …”
-
4844
MXene-Coated Liquid Metal Nanodroplet Aggregates
Published 2025“…In contrast to silicone-based composites containing LM droplets or MXene nanosheets alone, these MXene-LM-silicone-based composites exhibit an exponential increase in thermal and electrical conductivity with decreasing interfacial thickness with significantly lower LM volume fractions (25 vol %) while avoiding LM rupture and bleed-out. …”
-
4845
Flow chart of inclusion and exclusion criteria.
Published 2025“…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”
-
4846
Baseline characteristics of study participants.
Published 2025“…Contrary to AD, treatment of VV group was significantly associated with decreased risk of VD (HR: 0.566, 95% CI: 0.382–0.841). …”
-
4847
-
4848
-
4849
-
4850
-
4851
-
4852
-
4853
-
4854
-
4855
-
4856
-
4857
-
4858
-
4859
-
4860